首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.

Metformin Targets Mitochondrial Glycerophosphate Dehydrogenase to Control Rate of Oxidative Phosphorylation and Growth of Thyroid Cancer In Vitro and In Vivo.

导出 OA

翻译打印收藏纠错

第一作者： Shilpa,Thakur

第一单位： Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland.

作者： Shilpa,Thakur ^[1] ; Brianna,Daley ^[1] ; Kelli,Gaskins ^[2] ; Vasyl V,Vasko ^[3] ; Myriem,Boufraqech ^[2] ; Dhaval,Patel ^[2] ; Carole,Sourbier ^[4] ; Jeff,Reece ^[1] ; Sheue-Yann,Cheng ^[5] ; Electron,Kebebew ^[2] ; Sunita,Agarwal ^[1] ; Joanna,Klubo-Gwiezdzinska ^[6]

作者单位： Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland. ^[1] Endocrine Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland. ^[2] Department of Pediatrics, Uniformed Services University of the Health Sciences, Bethesda, Maryland. ^[3] Urologic Oncology Branch, National Cancer Institute, NIH, Bethesda, Maryland. ^[4] Laboratory of Molecular Biology, National Cancer Institute, NIH, Bethesda, Maryland. ^[5] Metabolic Disease Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, Maryland. joanna.klubo-gwiezdzinska@nih.gov. ^[6]